Novavax Inc (NAS:NVAX)
$ 9.44 0.32 (3.51%) Market Cap: 1.51 Bil Enterprise Value: 643.71 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 69/100

Q4 2019 Novavax Inc Earnings Call Transcript

Mar 11, 2020 / 08:30PM GMT
Release Date Price: $10.51 (-1.31%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Novavax Fourth Quarter 2019 Financial Results Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Erika Trahan, Senior Manager of Investor and Public Relations. Thank you. Please go ahead, ma'am.

Erika S. Trahan
Novavax, Inc. - Senior Manager of Investor & Public Relations

Thank you, operator. Good afternoon. I'd like to thank everyone who has joined today's call to discuss our fourth quarter 2019 operational highlights and financial results. A press release announcing earnings is currently available on our website at novavax.com, and an audio archive of this conference call will be available on our website later today.

Joining me on today's call are Stan Erck, President and CEO of Novavax; and John Trizzino, Chief Business Officer and Chief Financial Officer. Dr. Gregory Glenn, our President of Research and Development, will be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot